The Accuracy of Self-reported Data Concerning Recent Cannabis Use in the French Armed Forces
Overview
Authors
Affiliations
Background: The aims were to evaluate the accuracy of self-report of past-month cannabis use in a representative sample of French military staff members and to evaluate the scale of the prevarication bias.
Method: Data from three cross-sectional surveys conducted between 2005 and 2008 (n = 3493) were used. The characteristics of self-report (sensitivity, specificity, positive predictive value and negative predictive value) were computed using tetrahydrocannabinol detection in urine as the reference.
Results: The prevalence for past-month cannabis use was 16.1% and for positive testing was 13.4%. The discriminant power of self-report was good, with an area under the receiver operating characteristics curve 0.90. Specificity (94.5%) and negative predictive values (97.8%) were good, but sensitivity (85.7%) and positive predictive values (70.4%) were lower. The lowest sensitivity values were observed in the higher categories of personnel and in the Navy, which could reflect some prevarication in these sub-populations who might believe they were more exposed to sanctions if detected.
Conclusions: Despite certain limitations of urine analysis as a reference, because of its poor detection of occasional users, our study is in favour of good accuracy of self-reported data on cannabis use, even among the military. However, our results, derived from a population study, do not enable any assumptions on the validity of self-reported data collected during individual testing procedures for the purpose of improving occupational safety.
Murphy J, Dennhardt A, Utzelmann B, Borsari B, Ladd B, Martens M Psychol Addict Behav. 2024; 38(3):255-268.
PMID: 38271079 PMC: 11065625. DOI: 10.1037/adb0000988.
Walker K, Mackler S, Noble S, Gaudreault A, Mitchell S, Reid R CJC Open. 2023; 5(4):315-324.
PMID: 37124964 PMC: 10140739. DOI: 10.1016/j.cjco.2023.01.005.
Amiet D, Youssef G, Hagg L, Lorenzetti V, Parkes L, Solowij N Front Psychiatry. 2021; 11:599365.
PMID: 33384630 PMC: 7771276. DOI: 10.3389/fpsyt.2020.599365.
Destree L, Amiet D, Carter A, Lee R, Lorenzetti V, Segrave R Drugs Context. 2018; 7:212541.
PMID: 30263037 PMC: 6152614. DOI: 10.7573/dic.212541.
Cannabis exposure and risk of testicular cancer: a systematic review and meta-analysis.
Gurney J, Shaw C, Stanley J, Signal V, Sarfati D BMC Cancer. 2015; 15:897.
PMID: 26560314 PMC: 4642772. DOI: 10.1186/s12885-015-1905-6.